1. Home
  2. FMS

as 05-20-2024 11:35am EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Health Care

Misc Health and Biotechnology Services

Nasdaq

Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.

Founded: N/A Country:
Germany
Germany
Employees: N/A City: N/A
Market Cap: 13.1B IPO Year: 1996
Target Price: $24.00 AVG Volume (30 days): 462.4K
Analyst Decision: Hold Number of Analysts: 2
Dividend Yield: 2.89% Dividend Payout Frequency: Annual
EPS: 0.90 EPS Growth: -19.51
52 Week Low/High: $16.37 - $27.72 Next Earning Date: 05-07-2024
Revenue: $21,167,305,435 Revenue Growth: -0.41%
Revenue Growth (this year): 2.56% Revenue Growth (next year): 3.93%

Share on Social Networks: